Behavioral effects of novel enterosorbent Noolit on mice with mixed depression/anxiety-like state

Pharmacology Biochemistry and Behavior

Volumn 72, Issue 1-2, 2002, Pages 131-141

  Borodin, Ju I ^a   Kudryavtseva, N N ^b   Tenditnik, M V ^a,b   Rachkovskaya, L N ^a   Shurlygina, A V ^a   Trufakin, V A ^a  

^a RESEARCH INSTITUTE OF CLINICAL AND EXPERIMENTAL LYMPHOLOGY   (Russian Federation)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Anxiety; Defeat; Depression; Lithium; Noolit; Sensory contact model; Social stress

Indexed keywords

NOOLIT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG; ANTIDEPRESSANT AGENT; LITHIUM; NOOLITH;

ANIMAL BEHAVIOR; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SOCIAL INTERACTION; TRANQUILIZING ACTIVITY; ANIMAL; ANXIETY; C57BL MOUSE; COMPARATIVE STUDY; MOTOR ACTIVITY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SOCIAL BEHAVIOR;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; DEPRESSION; LITHIUM; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SOCIAL BEHAVIOR;

EID: 0036208386     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00735-3     Document Type: Article

References (54)

1. Antidepressants are both anxiogenic and anxiolytic
2. Comparative analysis of anxiety-like behavior in partition and plus-maze tests after agonistic interaction in mice
3. The changes in brain TPH and MAOA activity at the process of development of experimental depression induced by social confrontations
4. Chronic treatment with ipsapirone affects anxiety, but not depression in mice
5. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders
6. Maintenance treatment of major depression: A review of the literature
7. Enterosorption and enterosorbents
8. Approaches to the endoecological rehabilitation. Novosibirsk
9. Behavioral effects of enterosorbent Noolit
10. Effects of enterosorbent Noolit on behavioral and immunological parameters in mice with experimental depressive state
11. Efficacy of lithium in mania and maintenance therapy of bipolar disorder
12. Regulation of central serotonin transporters by chronic lithium: An autoradiographic study
13. The treatment of bipolar depression
14. Serotonergic mechanism of depression
15. Depression: The case for a monoamine deficiency
16. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder
17. Immune responses in male mice with aggressive and submissive behavior patterns: Strain differences
18. Inhibitors of inositol monophosphatase
19. Can social interaction be used to measure anxiety?
20. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
21. Changes of some parameters of immune status in male mice under influence of chronic social conflicts
22. Possibilities of therapeutic action of medical sorbents at the base of activated carbons
23. Comorbidity of mood and anxiety disorders
24. Behavioral consequences of repeated social defeat in the mouse: Preliminary evaluation of a potential animal model of depression
25. Possible implications of 5-HT function for the etiology and treatment of depression
26. The influence of calcium channel blockers on antidepressant effects
27. The sensory contact model for the study of aggressive and submissive behaviors in male mice
28. Experience of defeats decreases the behavioral reactivity to conspecific in the partition test
29. Behavioral and physiological markers of experimental depression induced by social conflicts (DISC)
30. Social model of depression in mice of C57BL/6J strain
31. Social success and voluntary ethanol consumption in mice of C57BL/6J and CBA/Lac strains
32. Neurobiology of lithium: An update
33. The use of the plus-maze to measure anxiety in the mouse
34. Treatment of depression with associated anxiety: Comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors
35. Treatment of bipolar depression, a review of the literature and a suggestion for an algorithm
36. Treatment of depression and concomitant anxiety
37. The influence of social conflicts on some parameters of non-specific immune resistance in mice
38. Depression: A new animal model sensitive to antidepressant treatment
39. Stress and emotionality: A multidimensional and genetic approach
40. The effect of lithium administration in animal models of depression: A short review
41. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: Comparison with carbamazepine and sodium valproate
42. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders
43. The elevated plus-maze: Pharmacology, methodology and ethology
44. Anxiety with depression: A treatment need
45. Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression
46. Antidepressants, old and new. A review of their adverse effects and toxicity in overdose
47. Melancholic features and response to lithium prophylaxis in mood disorders
48. Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders
49. On the functions of lithium: The mood stabilizer
50. Mood-stabilizing drugs in depression
51. Mixed anxiety and depression: Clinical implications